CN1239149C - 掩蔽味道的药物制剂及其制备方法 - Google Patents

掩蔽味道的药物制剂及其制备方法 Download PDF

Info

Publication number
CN1239149C
CN1239149C CNB028121465A CN02812146A CN1239149C CN 1239149 C CN1239149 C CN 1239149C CN B028121465 A CNB028121465 A CN B028121465A CN 02812146 A CN02812146 A CN 02812146A CN 1239149 C CN1239149 C CN 1239149C
Authority
CN
China
Prior art keywords
active ingredient
preparation
adsorbent
matrix
alkaline agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB028121465A
Other languages
English (en)
Chinese (zh)
Other versions
CN1529585A (zh
Inventor
P·贝古
J·肖万
D·施瓦布
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Aventis Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma SA filed Critical Aventis Pharma SA
Publication of CN1529585A publication Critical patent/CN1529585A/zh
Application granted granted Critical
Publication of CN1239149C publication Critical patent/CN1239149C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CNB028121465A 2001-06-21 2002-06-21 掩蔽味道的药物制剂及其制备方法 Expired - Fee Related CN1239149C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR01/08157 2001-06-21
FR0108157A FR2826274B1 (fr) 2001-06-21 2001-06-21 Formulation pharmaceutique au gout masque et son procede de preparation

Publications (2)

Publication Number Publication Date
CN1529585A CN1529585A (zh) 2004-09-15
CN1239149C true CN1239149C (zh) 2006-02-01

Family

ID=8864587

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB028121465A Expired - Fee Related CN1239149C (zh) 2001-06-21 2002-06-21 掩蔽味道的药物制剂及其制备方法

Country Status (41)

Country Link
US (2) US7138138B2 (enExample)
EP (1) EP1401397B1 (enExample)
JP (1) JP4880871B2 (enExample)
CN (1) CN1239149C (enExample)
AP (1) AP1595A (enExample)
AR (1) AR036096A1 (enExample)
AT (1) ATE290366T1 (enExample)
AU (1) AU2002329311B2 (enExample)
BG (1) BG66314B1 (enExample)
BR (1) BRPI0208998A2 (enExample)
CA (1) CA2452239C (enExample)
CO (1) CO5540278A2 (enExample)
CZ (1) CZ299947B6 (enExample)
DE (1) DE60203178T2 (enExample)
EA (1) EA006016B1 (enExample)
EC (1) ECSP034915A (enExample)
ES (1) ES2236574T3 (enExample)
FR (1) FR2826274B1 (enExample)
GT (2) GT200200115A (enExample)
HR (1) HRP20031067B1 (enExample)
HU (1) HUP0400799A3 (enExample)
IL (2) IL159404A0 (enExample)
JO (1) JO2325B1 (enExample)
MA (1) MA27042A1 (enExample)
MX (1) MXPA03011756A (enExample)
MY (1) MY134340A (enExample)
NO (1) NO332258B1 (enExample)
NZ (1) NZ530042A (enExample)
OA (1) OA12635A (enExample)
PA (1) PA8548301A1 (enExample)
PE (1) PE20030201A1 (enExample)
PL (1) PL202090B1 (enExample)
PT (1) PT1401397E (enExample)
SK (1) SK285865B6 (enExample)
SV (1) SV2003001098A (enExample)
TN (1) TNSN03141A1 (enExample)
TW (1) TWI228049B (enExample)
UA (1) UA77960C2 (enExample)
UY (1) UY27341A1 (enExample)
WO (1) WO2003000225A2 (enExample)
ZA (1) ZA200309479B (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7384921B2 (en) * 2004-02-20 2008-06-10 Enanta Pharmaceuticals, Inc. Polymorphic forms of 6-11 bicyclic ketolide derivatives
GB2419094A (en) * 2004-10-12 2006-04-19 Sandoz Ag Pharmaceutical composition of unpleasnt tasing active substances
FR2882522B1 (fr) 2005-02-25 2007-04-13 Aventis Pharma Sa Composition pharmaceutique solide comprenant de la telithromycine
US7384922B2 (en) * 2005-05-04 2008-06-10 Enanta Pharmaceuticals, Inc. 6-11 bridged oxime erythromycin derivatives
US20060264386A1 (en) * 2005-05-17 2006-11-23 Rongqi Sun Pharmaceutical formulations of 6-11 bicyclic ketolide derivatives and related macrolides and methods for preparation thereof
KR101387249B1 (ko) * 2006-02-03 2014-05-21 에보니크 룀 게엠베하 물에 난용성인 유효 성분과 중합체의 혼합물을 함유하는제약 조성물
WO2007108010A2 (en) * 2006-03-21 2007-09-27 Jubilant Organosys Limited Taste masked pharmaceutical composition for oral solid dosage form and process for preparing the same using magnesium aluminium silicate
WO2008094877A2 (en) * 2007-01-30 2008-08-07 Drugtech Corporation Compositions for oral delivery of pharmaceuticals
KR100935893B1 (ko) * 2007-09-11 2010-01-07 국방과학연구소 1,1'-다이메틸-5,5’-바이테트라졸의 합성방법
US9453042B2 (en) 2007-10-25 2016-09-27 Cempra Pharmaceuticals, Inc. Process for the preparation of macrolide antibacterial agents
DK2379635T3 (en) 2008-12-16 2016-12-05 Carlsberg As Cellulosic polymer material
IN2014DN08939A (enExample) 2012-03-27 2015-05-22 Cempra Pharmaceuticals Inc
DE102012014848A1 (de) * 2012-07-27 2012-10-31 Heilerde-Gesellschaft Luvos Just GmbH & Co. KG Heilerde-Zubereitung
RU2017104163A (ru) * 2014-08-05 2018-09-06 Семпра Фармасьютикалз, Инк. Порошкообразные составы пероральных суспензий антибактериальных агентов
US10982177B2 (en) 2017-09-18 2021-04-20 The Clorox Company Cleaning wipes with particular lotion retention and efficacy characteristics
CN114209661B (zh) * 2022-02-21 2022-04-29 北京罗诺强施医药技术研发中心有限公司 呈细粒形式的固体药物组合物

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2930409A1 (de) * 1979-07-26 1981-02-12 Bayer Ag Spruehtrocknung von mikrokapseldispersionen
JPS63150220A (ja) * 1986-12-15 1988-06-22 Dainippon Pharmaceut Co Ltd 経口用固形製剤の製造方法
US4808411A (en) * 1987-06-05 1989-02-28 Abbott Laboratories Antibiotic-polymer compositions
US5084278A (en) * 1989-06-02 1992-01-28 Nortec Development Associates, Inc. Taste-masked pharmaceutical compositions
ZA945944B (en) * 1993-08-13 1996-02-08 Eurand America Inc Procedure for encapsulating nsaids
AUPN969796A0 (en) * 1996-05-07 1996-05-30 F.H. Faulding & Co. Limited Taste masked liquid suspensions
JP2001518490A (ja) * 1997-10-03 2001-10-16 エラン コーポレーシヨン ピーエルシー 味遮蔽された製剤
IN191239B (enExample) * 1999-06-11 2003-10-11 Ranbaxy Lab Ltd
US6555569B2 (en) * 2000-03-07 2003-04-29 Pfizer Inc. Use of heteroaryl substituted N-(indole-2-carbonyl-) amides for treatment of infection
ES2313975T3 (es) * 2000-08-22 2009-03-16 Basilea Pharmaceutica Ag Nuevos macrolidos con actividad antibacteriana.

Also Published As

Publication number Publication date
TNSN03141A1 (fr) 2005-12-23
US20070014857A1 (en) 2007-01-18
PL366803A1 (en) 2005-02-07
OA12635A (fr) 2006-06-15
WO2003000225A3 (fr) 2003-03-13
HRP20031067B1 (en) 2011-10-31
ATE290366T1 (de) 2005-03-15
BG108458A (bg) 2005-02-28
BG66314B1 (bg) 2013-04-30
HK1067558A1 (en) 2005-04-15
CZ20033441A3 (en) 2004-03-17
EP1401397B1 (fr) 2005-03-09
PE20030201A1 (es) 2003-03-12
HRP20031067A2 (en) 2004-04-30
NZ530042A (en) 2005-09-30
UY27341A1 (es) 2003-01-31
MY134340A (en) 2007-12-31
TWI228049B (en) 2005-02-21
PT1401397E (pt) 2005-05-31
AP2003002927A0 (en) 2003-12-31
PA8548301A1 (es) 2003-09-05
CA2452239C (fr) 2011-07-19
GT200200115A (es) 2003-02-27
FR2826274B1 (fr) 2003-09-26
SK285865B6 (sk) 2007-10-04
MA27042A1 (fr) 2004-12-20
PL202090B1 (pl) 2009-06-30
ZA200309479B (en) 2005-04-26
GT200200115AA (es) 2005-01-12
AR036096A1 (es) 2004-08-11
CZ299947B6 (cs) 2009-01-07
HUP0400799A2 (hu) 2004-08-30
ES2236574T3 (es) 2005-07-16
DE60203178D1 (de) 2005-04-14
JO2325B1 (en) 2006-06-28
HUP0400799A3 (en) 2012-08-28
JP2004534810A (ja) 2004-11-18
NO20035581D0 (no) 2003-12-15
CA2452239A1 (fr) 2003-01-03
EP1401397A2 (fr) 2004-03-31
DE60203178T2 (de) 2006-01-26
BRPI0208998A2 (pt) 2017-06-06
JP4880871B2 (ja) 2012-02-22
EA200400061A1 (ru) 2004-06-24
NO332258B1 (no) 2012-08-13
FR2826274A1 (fr) 2002-12-27
IL159404A0 (en) 2004-06-01
WO2003000225A2 (fr) 2003-01-03
US20040142029A1 (en) 2004-07-22
MXPA03011756A (es) 2004-07-01
EA006016B1 (ru) 2005-08-25
UA77960C2 (en) 2007-02-15
US7138138B2 (en) 2006-11-21
CO5540278A2 (es) 2005-07-29
AU2002329311B2 (en) 2007-02-01
IL159404A (en) 2007-08-19
CN1529585A (zh) 2004-09-15
ECSP034915A (es) 2004-02-26
SV2003001098A (es) 2003-03-18
SK15922003A3 (sk) 2004-05-04
AP1595A (en) 2006-04-12

Similar Documents

Publication Publication Date Title
CN1239149C (zh) 掩蔽味道的药物制剂及其制备方法
CN1150893C (zh) 带两层包衣的药物组合物
CN1174740C (zh) 掩味的药用液体制剂
CN101137350B (zh) 包含利福昔明的胃稳定药物制剂
CN1125636C (zh) 含有口服活性β－内酰胺的颗粒制备方法
CN1187052C (zh) 含有司他夫定(stavudine)的持续释放微球
CN1198611C (zh) 药物抗菌剂组合物
CN1744881A (zh) 苦味减轻了的药物组合物
CN1210065C (zh) 具有改善溶出性能的普仑司特的固体分散体系及其制备方法
CN1421206A (zh) 药物组合物
US20230381265A1 (en) Oligosaccharide formulations of kappa opioid receptor agonists
CN1635872A (zh) 前脂质体药物传递系统
CA2533150C (en) A doxycycline metal complex in a solid dosage form
HK1067558B (en) Pharmaceutical formulation having a masked taste and method for the production thereof
CN1652750A (zh) 红霉素a及其衍生物的味道掩蔽组合物
CN1803128A (zh) 含有盐酸曲马多和对乙酰氨基酚的口崩片及其制备方法

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1067558

Country of ref document: HK

C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20060201

Termination date: 20150621

EXPY Termination of patent right or utility model